These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34801282)

  • 1. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
    J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
    Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot implementation study to scale-up methadone in incarcerated persons with opioid use disorder and retain them on treatment after release in Moldova.
    Dorgay CE; Bromberg DJ; Doltu S; Litz T; Galvez S; Polonsky M; Dvoryak S; Altice FL
    Int J Drug Policy; 2022 Jun; 104():103683. PubMed ID: 35417790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing methadone maintenance treatment in prisons in Malaysia.
    Wickersham JA; Marcus R; Kamarulzaman A; Zahari MM; Altice FL
    Bull World Health Organ; 2013 Feb; 91(2):124-9. PubMed ID: 23554524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decisional considerations for methadone uptake in Kyrgyz prisons: The importance of understanding context and providing accurate information.
    Liberman AR; Bromberg DJ; Azbel L; Rozanova J; Madden L; Meyer JP; Altice FL
    Int J Drug Policy; 2021 Aug; 94():103209. PubMed ID: 33838398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
    Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
    Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study.
    Hayashi K; Ti L; Ayutthaya PPN; Suwannawong P; Kaplan K; Small W; Kerr T
    Harm Reduct J; 2017 Sep; 14(1):63. PubMed ID: 28882155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative study of diphenhydramine injection in Kyrgyz prisons and implications for harm reduction.
    Meyer JP; Culbert GJ; Azbel L; Bachireddy C; Kurmanalieva A; Rhodes T; Altice FL
    Harm Reduct J; 2020 Oct; 17(1):86. PubMed ID: 33129341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.
    Polonsky M; Rozanova J; Azbel L; Bachireddy C; Izenberg J; Kiriazova T; Dvoryak S; Altice FL
    AIDS Behav; 2016 Dec; 20(12):2950-2960. PubMed ID: 27011378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in Iran.
    Zamani S; Farnia M; Torknejad A; Alaei BA; Gholizadeh M; Kasraee F; Ono-Kihara M; Oba K; Kihara M
    J Urban Health; 2010 Jul; 87(4):603-16. PubMed ID: 20390391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons.
    Liberman AR; Bromberg DJ; Litz T; Kurmanalieva A; Galvez S; Rozanova J; Azbel L; Meyer JP; Altice FL
    PLoS One; 2022; 17(10):e0276723. PubMed ID: 36282864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality among a cohort of drug users after their release from prison: an evaluation of the effectiveness of a harm reduction program in Taiwan.
    Huang YF; Kuo HS; Lew-Ting CY; Tian F; Yang CH; Tsai TI; Gange SJ; Nelson KE
    Addiction; 2011 Aug; 106(8):1437-45. PubMed ID: 21438941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.